March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Nodal Signaling Pathway: A Novel Developmental Pathway Possibly Driving Retinoblastoma Tumorigenesis
Author Affiliations & Notes
  • Geeta K. Vemuganti
    School of Medical Sciences, University of Hyderabad, Hyderabad, India
  • Rohini Nair
    School of Medical Sciences, University of Hyderabad, Hyderabad, India
  • Murali M Sagar Balla
    Sudhakar and Sreekant Ravi Stem Cell Biology Laboratory, L V Prasad Eye Institute, Hyderabad, India
  • Chitra Kannabiran
    Kallam Anji Reddy Molecular Genetics Lab,
    LV Prasad Eye Institute, Hyderabad, India
  • Santosh G. Honavar
    LV Prasad Eye Institute, Hyderabad, India
  • Ali M. Javed
    LV Prasad Eye Institute, Hyderabad, India
  • Imran Khan
    Indian Institute of Science, Bangalore, India
  • Ravi Kiran Reddy Kalathur
    Indian Institute of Science, Bangalore, India
  • Kondaiah Paturu
    Indian Institute of Science, Bangalore, India
  • Footnotes
    Commercial Relationships  Geeta K. Vemuganti, None; Rohini Nair, None; Murali M Sagar Balla, None; Chitra Kannabiran, None; Santosh G. Honavar, None; Ali M. Javed, None; Imran Khan, None; Ravi Kiran Reddy Kalathur, None; Kondaiah Paturu, None
  • Footnotes
    Support  Indian Council of Medical Research/Hyderabad Eye Research Foundation
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1291. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Geeta K. Vemuganti, Rohini Nair, Murali M Sagar Balla, Chitra Kannabiran, Santosh G. Honavar, Ali M. Javed, Imran Khan, Ravi Kiran Reddy Kalathur, Kondaiah Paturu; Nodal Signaling Pathway: A Novel Developmental Pathway Possibly Driving Retinoblastoma Tumorigenesis. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1291.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Recent evidence points to the presence of putative cancer stem cell population in Retinoblastoma (Rb) that are characterized by the size and phenotype of cells, gene expression pattern, metastatic pathways and to some extent, response to drugs. In this study, we aim to evaluate the role of Nodal/Activin pathway in Rb, which is known to play a crucial role in development, neural patterning and maintaining the undifferentiated state of human Embryonic Stem Cells (hESCs).

Methods: : After IRB approval and informed consent, freshly isolated tumor and normal appearing retina (n=2) were harvested from enucleated eyes of patients with Rb (n=11). Total RNA was isolated and processed according to manufacturer’s protocol. Microarray was performed using human whole genome (4x44K) cDNA arrays (Agilent technologies, USA) and data was normalized and analyzed. Real-Time PCR was done (using RNA from tissues) to validate the results of gene expression (for expression of Nodal receptor- Activin receptor 1C (ACVR1C), HMGA2, LIN-28band N-Myc) in tissues compared to the two control retinas. Further, immunolocalization for ACVR1C expression on tissue sections (n=19).

Results: : In Rb tumors, of the 10,457 genes that were deregulated (p ≤ 0.05 and fold change ≥ 1.5 folds), significant up-regulation of ACVR1C (2.23 fold) and its downstream effector, SMAD3(2.43 fold) was observed. The ligands for this pathway such as NODAL and TGFB were found to be unregulated and the inhibitor, LEFTY, was unregulated in these tumors. ACVR1C showed higher expression in poorly differentiated tumors as compared to well differentiated tumors. Also, HMGA2 (48.6 fold) and its downstream regulator, LIN-28b (2.1 fold), were found to be highly up-regulated in primary tumors.

Conclusions: : This study highlights the deregulation of genes involved in Nodal signaling such as ACVR1C, SMAD3, LEFTY, etc. This is in concordance with evidence of elevated Nodal pathway in highly aggressive gliomas, ovarian, pancreatic tumors, etc. Further functional studies, specifically in the cancer stem cells population in Rb, would improve the understanding of tumorigenesis and possibly pave way for targeted therapy.

Keywords: retinoblastoma • gene/expression • immunohistochemistry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×